C-type Natriuretic Peptide (CNP): Cardiovascular Roles and Potential as a Therapeutic Target

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|16|37|4080-4088

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.37, 2010-12, pp. : 4080-4088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of C-type natriuretic peptide on renal vasoconstriction in dogs

By Yoshida K.   Yamagata T.   Tomura Y.   Suzuki-Kusaba M.   Yoshida M.   Hisa H.   Satoh S.  

European Journal of Pharmacology, Vol. 338, Iss. 2, 1997-11 ,pp. : 131-134

Elsevier

Access to resources Recommend Favorite

C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes

By Nir A.   Zhang D.F.   Fixler R.   Burnett J.C.   Eilam Y.   Hasin Y.  

European Journal of Pharmacology, Vol. 412, Iss. 3, 2001-02 ,pp. : 195-201

Elsevier

Access to resources Recommend Favorite

Vasodilator effects of C-type natriuretic peptide on cerebral arterioles in rats

By Mori Y.   Takayasu M.   Suzuki Y.   Shibuya M.   Yoshida J.   Hidaka H.  

European Journal of Pharmacology, Vol. 320, Iss. 2, 1997-02 ,pp. : 183-186

Elsevier

Access to resources Recommend Favorite

Opposing effects of endothelin-1 on C-type natriuretic peptide actions in rat cardiomyocytes

By Fixler R.   Hasin Y.   Eilam Y.   Zhang D.F.   Nir A.  

European Journal of Pharmacology, Vol. 423, Iss. 2, 2001-07 ,pp. : 95-98

Elsevier

Access to resources Recommend Favorite

The Potential Roles of Metallothionein as a Therapeutic Target for Cerebral Ischemia and Retinal Diseases

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 4, 2013-01 ,pp. : 400-407

Bentham Science Publishers

Access to resources Recommend Favorite